- Lobbying
- Lobbying by Allergan, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Dave Boyer | Sp Asst Pres LA, Asst Com Leg, FDA,Con Asst, Off of Sec Lab Sp Asst Sec HHS, Con Asst, Off of WH Liaison DoD See prior filing |
Bob Wood | Chief of Staff to HHS Secretary |
Jennifer Larkin Lukawski | Leg. Dir. Rep. Dornan, Ex. Dir. Hs. Con. Ac. Team See prior filing |
Bill Viney | Aide to Rep. Scott Klug See prior filing |
Ryan Long | Prof. Stf, Csel, & Chief Csel H E&C Cmte LC Rep Norwood; LA& LD Rep Barton See prior filing |
Erskine Wells | Dep COS Sen. Wicker, COS Rep. Palazzo Dep Leg Dir Sen Wicker, Leg Asst Sen Wicker See prior filing |
Robert Wood | See prior filing |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Monitor, advise, and as appropriate directly advocate on healthcare and tax policy issues related to Allergan specifically and the lifesciences industry generally..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate